Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sulfonylurea Compounds × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 194 pembrolizumab 171 Magnetic Resonance Spectroscopy 156 Biopsy 115 Carboplatin 113 Cisplatin 93 Cyclophosphamide 91 Paclitaxel 75 venetoclax 69 Bevacizumab 68 Nivolumab 65 Gemcitabine 65 Radiotherapy 57 Dexamethasone 55 Rituximab 50 fludarabine 49 Pemetrexed 48 Oxaliplatin 44 Fluorouracil 43 Docetaxel 40 Doxorubicin 38 atezolizumab 37 Capecitabine 37 durvalumab 35 Cetuximab 35 Prednisone 34 Leucovorin 34 Azacitidine 34 X-Rays 33 Radiation 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05663515 2026-03-19

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡